Dementia, the slow loss of the brain's ability to think, remember, and function, is one of the scariest health challenges out there, and cases are expected to nearly triple by 2050. There is no magic shield against it. But a study from Japan delivers a genuinely hopeful message: healthy choices can meaningfully lower your risk, even if you carry a gene that stacks the odds against you.

Researchers at Kyushu University and RIKEN followed 9,605 Japanese adults aged 65 and older. They checked each person's version of a gene called APOE (the single strongest genetic risk factor for Alzheimer's) and scored their lifestyle habits like blood pressure, physical activity, smoking, and diet.

The findings were striking. People carrying one copy of the risky APOE ε4 gene who lived healthier lives had a much lower dementia risk than those with worse habits. Brain scans backed it up: among people with zero or one copy of the gene, healthier living meant less brain shrinkage and fewer patches of damaged tissue.

But there was a sobering exception. For the small group carrying two copies of APOE ε4, the rules changed. These people had more than 10 times the dementia risk of non-carriers, and their risk barely budged based on lifestyle. Their brains showed more damage no matter how clean they lived. We will come back to this group, because their story matters.

What is APOE, and why does it punch so far above its weight?

To understand how one gene can swing brain health this hard, you need to know what APOE actually does. The name stands for apolipoprotein E, and its main day job is hauling cholesterol and fats around your body and brain. In the brain, it is made mostly by astrocytes, the star-shaped support cells that keep the neighborhood running.

The gene comes in three common versions: ε2, ε3, and ε4. You inherit two copies, one from each parent, so you might be ε3/ε3, ε3/ε4, ε4/ε4, and so on. The ε3 version is the most common and basically neutral. The ε2 version is the lucky one, it actually lowers Alzheimer's risk. The ε4 version is the troublemaker that raises it.

How much? Compared to ε3 carriers, having one ε4 copy roughly doubles to triples your risk. Having two copies pushes it 7 to 10 times higher, with a lifetime Alzheimer's risk of 40 to 60 percent. To put that in perspective, that is in the same ballpark as the breast cancer risk from a BRCA1 mutation. One small gene, an outsized shadow.

How APOE ε4 hurts the brain: the amyloid story

The main way APOE ε4 raises risk involves a protein fragment called amyloid-beta, or Aβ. In a healthy brain, Aβ is produced normally and then continuously swept away. In Alzheimer's, it piles up and clumps into sticky plaques between brain cells, jamming communication and stoking inflammation.

APOE is deeply involved in handling Aβ, and the three versions behave very differently. First, ε4 encourages Aβ to clump. Because of a subtle difference in its 3D shape, the ε4 protein grabs onto Aβ more readily and helps it seed into the toxic clusters that become plaques. Second, and maybe worse, ε4 slows the brain's cleanup crew. Normally Aβ gets cleared through several routes, including being absorbed by brain cells through a receptor called LRP1. The ε4 protein competes with Aβ for those same cleanup receptors but is clumsy at actually removing it, so Aβ lingers in the brain far longer than it should. Think of a janitor who keeps grabbing the mop but never quite cleans the floor.

Third, ε4 changes the timing of the whole disease. In ε4 carriers, amyloid starts building up earlier in life, and earlier still in people with two copies. In the protective ε2 carriers, it is delayed. Brain imaging and autopsy studies both confirm this. So a big part of what APOE does is set the clock on when trouble begins.

It is not just amyloid

APOE ε4's mischief goes well beyond plaques. It worsens tau pathology, where another protein forms tangles inside neurons and eventually kills them. It pushes the brain's immune cells, the microglia, toward a more damaging, inflamed state. It teams up with toxic Aβ clusters right at the synapses, the junctions where neurons talk, causing more of them to be lost. It promotes amyloid buildup in the walls of brain blood vessels, which can lead to tiny bleeds and poor blood flow. And it disrupts the brain's fat transport, throwing off the cholesterol delivery that keeps cell membranes and synapses healthy. In short, ε4 is not a one-trick villain. It causes problems on several fronts at once.

The good news: lifestyle genuinely moves the needle

Here is where it gets empowering. Despite that strong genetic pull, the Japanese study adds to a mountain of evidence that lifestyle can meaningfully cut dementia risk, even for genetically vulnerable people.

The 2024 Lancet Commission on Dementia Prevention identified 14 modifiable risk factors that, if properly managed, could prevent or delay up to 45 percent of all dementia cases worldwide. That is nearly half. These factors span your whole life. In early life, the big one is lower education. In midlife, the list includes hearing loss, high blood pressure, smoking, obesity, depression, physical inactivity, diabetes, heavy drinking, traumatic brain injury, and high LDL cholesterol. In late life, it is social isolation, untreated vision loss, and air pollution.

Any single factor only nudges your risk a little. But stack several together and the combined effect is substantial. The flip side is the encouraging part: each factor you fix is a brick you remove from the load.

A landmark 2019 study in JAMA drove this home. It analyzed nearly 200,000 people in the UK Biobank and found that genetic risk and healthy living act independently. People with high genetic risk and an unhealthy lifestyle had nearly triple the dementia risk of people with low genetic risk and a healthy lifestyle. Crucially, a healthy lifestyle was linked to lower risk no matter what your genes looked like. Your DNA is not the final word.

Another study, from the Chicago Health and Aging Project, followed nearly 4,000 older adults and found that healthy habits (not smoking, staying physically and mentally active, eating well, and limiting alcohol) slowed cognitive decline in both ε4 carriers and non-carriers. Remarkably, the protective effect was even stronger in the ε4 carriers, the very people who need it most.

There is nuance, though. A 2025 review of 170 studies found that APOE ε4 status actually changes which risk factors matter most. For example, physical activity and diabetes mattered more for non-carriers, while the benefits of statins and certain anti-inflammatory drugs were stronger in carriers. This hints that ε4 may drive a somewhat different road to dementia, which opens the door to prevention plans tailored to your genes.

How exercise actually protects your brain

Physical activity is one of the most reliably protective habits. A meta-analysis of 58 studies found it was tied to a 20 percent lower risk of dementia overall and a 14 percent lower risk of Alzheimer's specifically, even in studies that followed people for 20-plus years. That long follow-up matters, because it rules out the worry that people simply stop exercising once early dementia sets in. Data from the Framingham Heart Study showed that being active in both midlife and late life lowered risk, and that in older age, even light activity helped.

Scientists have mapped at least five ways exercise guards the brain. It calms chronic brain inflammation and slows Aβ from clumping, partly by boosting a cleanup protein called clusterin. It improves the brain's ability to flush out Aβ, including through the glymphatic system, the brain's waste-rinse cycle that runs mainly during sleep. It pumps up a protein called BDNF that helps neurons survive, grow, and strengthen, especially in the hippocampus, the memory hub that Alzheimer's attacks first. It stimulates the birth of brand-new neurons in that same hippocampus, a process called neurogenesis. And it builds "cognitive reserve," the brain's knack for finding backup routes when its usual pathways are damaged, letting it tolerate more disease before symptoms show.

On top of all that, exercise works indirectly too. It lowers blood pressure, improves how your body handles sugar, cuts LDL cholesterol, reduces obesity, improves sleep, and eases depression, every one of which is its own dementia risk factor. One habit, many wins.

Back to the two-copy group

Now the hard part. The Japanese study found that lifestyle changes did not significantly lower dementia risk in people with two copies of APOE ε4, who make up about 2 to 3 percent of the population and face that 40 to 60 percent lifetime risk. The likely reason is biological: their disruption of amyloid handling, fat transport, and inflammation runs so deep that healthy habits alone may not be enough to overcome it.

As lead researcher Professor Toshiharu Ninomiya put it, people carrying two ε4 copies may need earlier intervention and new approaches beyond lifestyle and health management. That is not a reason for them to give up on healthy living, which helps the heart and body regardless, but it is a reason to look harder at medicine. Emerging options include anti-amyloid antibodies like lecanemab and donanemab that clear plaques directly, and experimental therapies aimed at the APOE protein itself. The science is moving fast.

The bottom line

For the vast majority of people, including those carrying a single ε4 copy, a healthy lifestyle can meaningfully shrink dementia risk. The proven recipe is familiar: move your body regularly, control blood pressure, eat well, stay socially and mentally engaged, take care of your hearing and vision, limit alcohol, and do not smoke. These are not just good for your heart. They are good for your brain.

And timing counts. Many of the Lancet Commission's risk factors operate in midlife, decades before any symptoms appear, so the earlier you start, the more you protect. The message is both humbling and hopeful. Your genes may load the gun, but for most people, your daily choices help decide whether the trigger ever gets pulled.

This article is for general education and isn't medical advice. Most people don't know their APOE status, and you don't need to in order to act on the message here — the lifestyle factors that reduce dementia risk are also the lifestyle factors that reduce heart disease, diabetes, and many cancers, so the effort pays off whether or not you carry an ε4 copy. If dementia runs in your family or you have specific concerns, talk to your primary care doctor or a memory clinic — genetic counseling exists for people considering APOE testing, and that conversation matters because knowing your status can be useful or distressing depending on the person. For the two-copy ε4 population specifically, anti-amyloid antibody therapies (lecanemab, donanemab) are now FDA-approved and the field is moving fast — a memory specialist or neurologist is the right referral.